Quarterly report · Q2
4188.TEDINET S100PK3O
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.27T | 2022-04-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥1.16T | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥3.98T | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.89T | 2021-04-01 → 2021-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥956.8bn | 2021-07-01 → 2021-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥118.4bn | 2022-04-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥50.3bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥153.1bn | 2021-04-01 → 2021-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥66.1bn | 2021-07-01 → 2021-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥122.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥46.9bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥290.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥147.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥61.9bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥73.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥29.1bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥177.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥85.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥35.2bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥91.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥38.2bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥209.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥101.9bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥42.7bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥6.00T | at 2022-09-30 | Cons. | Assets IFRS |
| Total assets | ¥5.57T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥5.32T | at 2021-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.96T | at 2022-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥3.73T | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.04T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.84T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.67T | at 2021-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.57T | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.63T | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.46T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.32T | at 2021-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥253.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥245.8bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥257.7bn | at 2021-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥349.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥93.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥346.9bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥166.3bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥117.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥128.8bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥107.5bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥15.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥336.3bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥151.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥52.02 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥20.44 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥124.68 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥59.94 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥24.8 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥49.79 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.58 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥115.03 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥55.13 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥22.82 | 2021-07-01 → 2021-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 27.1% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 26.2% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 24.8% | at 2021-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥205.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥108.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥96.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥6.6bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥152.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥152.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥6.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥771.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥745.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥26.0bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥22.7bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥212.3bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥212.0bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥309m |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥573.7bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥569.3bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥54.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥659.7bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥634.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥25.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥42.3bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.22T |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.16T |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥56.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥122.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.42T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.27T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥152.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥129.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥172.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥81.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥90.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥6.1bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥140.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥140.6bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥7.3bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥614.8bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥593.9bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥20.9bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥62.2bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥198.7bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥198.5bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥171m |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥447.4bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥444.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥48.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥592.2bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥566.7bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥25.5bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥45.8bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥1.85T |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.80T |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥49.8bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥157.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥2.03T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.89T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥140.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥163.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 950
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenue IFRS | CurrentYTDDuration | 2269808000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000PerformanceProductsReportableSegmentMember | 42264000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000ChemicalsReportableSegmentMember | 22739000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000IndustrialGasesReportableSegmentMember | 54252000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000HealthCareReportableSegmentMember | 3146000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_ReportableSegmentsMember | 122401000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 6649000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 129050000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_ReconcilingItemsMember | -6429000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration | 122621000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration | 156140000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration | 122621000000 | JPY |
| Gain on reversal of environmental expenses IFRS | Prior1YTDDuration | - | JPY |
| Gain on reversal of environmental expenses IFRS | CurrentYTDDuration | 2389000000 | JPY |
| Gain on sale of fixed assets adjustments to profit before tax IFRS | Prior1YTDDuration | 1782000000 | JPY |
| Gain on sale of fixed assets adjustments to profit before tax IFRS | CurrentYTDDuration | 647000000 | JPY |
| Gain on sale of investments in subsidiaries and associates adjustments to profit before tax IFRS | Prior1YTDDuration | 1886000000 | JPY |
| Gain on sale of investments in subsidiaries and associates adjustments to profit before tax IFRS | CurrentYTDDuration | - | JPY |
| Loss on arbitration award IFRS | Prior1YTDDuration | - | JPY |
| Loss on arbitration award IFRS | CurrentYTDDuration | 3502000000 | JPY |
| Impairment losses adjustments to profit before tax IFRS | Prior1YTDDuration | 1898000000 | JPY |
| Impairment losses adjustments to profit before tax IFRS | CurrentYTDDuration | 1894000000 | JPY |
| Loss on sale and retirement of fixed assets adjustments to profit before tax IFRS | Prior1YTDDuration | 2702000000 | JPY |
| Loss on sale and retirement of fixed assets adjustments to profit before tax IFRS | CurrentYTDDuration | 1411000000 | JPY |
| Other adjustments to profit before tax IFRS | Prior1YTDDuration | 2071000000 | JPY |
| Other adjustments to profit before tax IFRS | CurrentYTDDuration | 498000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 153137000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | 118352000000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 5418000000 | JPY |
| Finance income IFRS | CurrentYTDDuration | 16538000000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | 11390000000 | JPY |
| Finance costs IFRS | CurrentYTDDuration | 12923000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 147165000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 121967000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-11-11 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第18期第2四半期(自 2022年7月1日 至 2022年9月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)三菱ケミカルグループ株式会社 | |
| Company name in english cover page | FilingDateInstant | Mitsubishi Chemical Group Corporation | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)執行役社長 ジョンマーク・ギルソン | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都千代田区丸の内一丁目1番1号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | (03)6748-7200 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Text · Plus | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都千代田区丸の内一丁目1番1号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | (03)6748-7200 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Text · Plus | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00808 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |